No abstract available
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Azacitidine / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cytoplasm / ultrastructure*
-
Dexamethasone / administration & dosage
-
Dexamethasone / adverse effects
-
Diagnostic Errors*
-
Erythroblasts / ultrastructure*
-
Fatal Outcome
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Lenalidomide
-
Leukemia, Erythroblastic, Acute / blood
-
Leukemia, Erythroblastic, Acute / diagnosis*
-
Leukemia, Erythroblastic, Acute / pathology
-
Male
-
Multiple Myeloma / blood
-
Multiple Myeloma / diagnosis*
-
Myelodysplastic Syndromes / blood*
-
Myelodysplastic Syndromes / chemically induced
-
Myelodysplastic Syndromes / pathology
-
Thalidomide / analogs & derivatives
-
Thalidomide / therapeutic use
Substances
-
Thalidomide
-
Dexamethasone
-
Cyclophosphamide
-
Lenalidomide
-
Azacitidine